Survival in a population-based cohort of dementia patients: predictors and causes of mortality
β Scribed by Froukje Boersma; Wim Van Den Brink; Dorly J. H. Deeg; Jan A. Eefsting; Willem Van Tilburg
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 82 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0885-6230
No coin nor oath required. For personal study only.
β¦ Synopsis
Objectives. To examine predictors of survival time and causes of mortality in a population-based cohort of demented subjects.
Design. Longitudinal naturalistic follow-up study.
Setting. A rural area in The Netherlands.
Participants. The study population consisted of 102 demented subjects derived from a population-based, two-stage prevalence study of dementia among subjects aged 65 and over.
Measurements and analysis. Survival analysis was performed using the Realized Probability of Dying as a measure of survival time. Adjustment for duration and severity at study entry was employed in all analyses.
Results. A substantial excess mortality was present among demented subjects as compared with their nondemented birth cohort. Disorders related to dementia, such as cachexia, dehydration and pneumonia, were major causes of death. Variables related to severity of functional impairment, aphasia and a shorter duration at study entry predicted a shorter survival in the study population.
π SIMILAR VOLUMES
## BACKGROUND. Colon carcinoma primarily affects persons 65 years and older. Seventy-five percent of the incident tumors affect persons in this age group. Because of their advanced age, older patients already may be coping with other concomitant major physical illnesses. This article documents p
## Objective: This study was undertaken to analyze standardized mortality ratios (smrs) and causes and predictors of death in primary sjΓΆgren's syndrome (ss) diagnosed according to 3 different classification criteria sets (the copenhagen criteria, the european criteria, and the american-european co
Mycosis fungoides is the most common cutaneous lymphoma in the US, and it is increasing rapidly in both incidence and mortality. Our knowledge of its prognosis derives primarily from case series, which are subject to possible selection bias and other limitations. The current analysis examines trends